Frequency and characteristics of promissory conference abstracts, i.e. abstracts without results, accepted at Cochrane Colloquia 1994-2020.

BACKGROUND: The purpose of a conference abstract is to summarize the main points of a research-related report that will be presented at an academic conference. However, some conferences accept and publish abstracts without results, which is contrary to the basic idea of a conference abstract as a dissemination tool. A conference abstract without results included is called a "promissory abstract". This study aimed to analyze the frequency and characteristics of promissory conference abstracts, i.e. abstracts submitted without results, accepted at Cochrane Colloquia. METHODS: We analyzed 8297 conference abstracts accepted at 25 Cochrane Colloquia, organized in 1994-2020, which were publicly available on the website of the Cochrane Library. Two authors screened abstracts to identify promissory abstracts. We extracted characteristics of promissory abstracts. RESULTS: Among abstracts accepted for Cochrane Colloquia, 8.7% were promissory; 475 (66%) were accepted as poster presentations, 241 (34%) as oral presentations and 1 as a workshop. The median number of authors in promissory abstracts was 4 (interquartile range: 3 to 6 authors). In 245 (34%) promissory abstracts, affiliations of authors were not reported. The authors were most commonly affiliated with the following countries: UK (472; 36%), Canada (N = 123; 26%), China (N = 76; 16%), United States (N = 66; 14%) and Australia (N = 53; 11%). There were 512 (71%) promissory abstracts in which study design was not reported. CONCLUSION: Promissory abstracts were commonly accepted at Cochrane Colloquia. Such abstracts deserve further attention, as they are detrimental in terms of the dissemination of new knowledge presented at a conference. Conference organizers could ask authors to update the abstract results subsequently to enable the dissemination of information presented at a conference.

Summary of the 11th International Conference on Human Herpesviruses-6A, -6B, and -7.

The 11th International Conference on Human Herpesviruses (HHV)-6A, -6B, and -7 was held in Quebec City, from 23 to 26 June 2019. It attracted 144 basic, translational, and clinical scientists from 20 countries. Important new information was presented regarding: the mechanisms of chromosomal integration for HHV-6A and -6B; the biology of inherited chromosomally integrated HHV-6A and -6B; animal models for, and animal viruses with similarities to, HHV-6A, -6B, and -7; established and possible disease associations, including provocative new information suggesting these viruses may be one trigger of Alzheimer's disease, and new treatment strategies. In this review, we summarize presentations that were of particular interest. The full text of the Abstracts cited in the manuscript is available in the online Supporting Information Materials.

Proceedings of the 2023 Cannabis Clinical Outcomes Research Conference.

The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its third annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2023. CCORC was held as a hybrid conference, with a scientific program consisting of in-person sessions, with some sessions livestreamed to virtual attendees. CCORC facilitated and promoted up-to-date research on the clinical effects of medical cannabis, fostering collaboration and active involvement among scientists, policymakers, industry professionals, clinicians, and other stakeholders. Three themes emerged from conference sessions and speaker presentations: (1) disentangling conflicting evidence for the effects of medical cannabis on public health, (2) seeking solutions to address barriers faced when conducting clinical cannabis research - especially with medical cannabis use in special populations such as those who are pregnant, and (3) unpacking the data behind cannabis use and mental health outcomes. The fourth annual CCORC is planned for the summer of 2024 in Florida, USA.

Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference.

The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.

Meeting the COVID Challenge to a Research-intensive Pre-college Science Education Program.

The objective of our program is to foster and facilitate authentic research experiences in middle and high school classrooms. We achieve this directly by providing students with a complete experience in scientific experimentation and communication. The centerpiece is a set of experiment modules which students use to investigate the effects of toxic chemicals on living organisms through the use of model organisms such as the earthworm, fathead minnow, and the zebrafish, and chemical contaminants commonly found in the environment. In parallel, we partner with the University of Wisconsin-Milwaukee science teacher certification program to prepare pre-service teachers to offer real research experiences in their future classrooms. With the COVID virus restricting or eliminating in-person learning, the program's challenge was (i) to create new ways to conduct experiments virtually that retain elements of the authentic research experience and (ii) to move all of the accompanying facets of the program to online formats. This paper will describe the new online materials and activities that were introduced this past year as well as the challenges they presented and the opportunities that they offer for the future.

The ninth International Conference of Anticancer Research, 6-10 October 2014, Sithonia, Greece.

The ninth conference of the International Institute for Anticancer Research, held in Sithonia, Greece in October 2014, included over 700 abstracts presented in 79 separate sessions and featured a wide range of topics in basic and clinical cancer research. This report describes a small but representative sample of these sessions. It covers some recent developments in research into the basic signal transduction pathways involved in carcinogenesis; a special session on the role of homeobox genes in cancer development; and clinical sessions covering advances in breast cancer, haematological cancers, and chemotherapy.